Publications by authors named "G Gleda Ang"
Introduction: The aim of this study was to investigate the efficacy of limiting increases in theatre ambient temperature to 27°C to prevent intraoperative patient hypothermia.
Methods: This single-centre, comparative cohort clinical study investigated the management of theatre ambient temperatures involving patients with ≥ 20 % TBSA burn injuries at Victorian Adult Burns Service (Melbourne, Australia). Data from the intervention group (August 2021 - February 2023, theatre ambient temperature increase limited to 27°C) was compared with a historical cohort (August 2019 - August 2021).
Antimicrobial Activity of (Cavs.) Pers. Ethanolic and Aqueous Leaf Extract on the Growth and Biofilm Formation of Selected Bacterial Isolates.
Acta Med Philipp
October 2024
Background: (Aunasin) is an endemic Philippine plant of the family Primulaceae, with several studies showing the genus Ardisia as having potential antibacterial, antiangiogenic, cytotoxic, and antipyretic properties.
Objective: This study aims to determine the antibacterial and antibiofilm-forming activity of ethanolic and aqueous extracts on , Methicillin-Sensitive (MSSA), and Methicillin-Resistant (MRSA).
Methods: This is an experimental study testing the activity against bacterial strains of , MSSA, and MRSA using ethanolic and aqueous extracts of leaves.
Background: Increasing physical inactivity is a primary risk factor for diabetes and hypertension, contributing to rising health care expenditure and productivity losses. As Singapore's aging population grows, there is an increased disease burden on Singapore's health systems. Large-scale physical activity interventions could potentially reduce the disease burden but face challenges with the uncertainty of long-term health impact and high implementation costs, hindering their adoption.
View Article and Find Full Text PDFArticle Synopsis
- * Results indicated that CPAP therapy is highly cost-effective, with an incremental cost-effectiveness ratio of $13,822 per disability-adjusted life year (DALY) averted, significantly below the US threshold of $50,000 per DALY.
- * The analysis highlighted that treatment costs, as well as patient adherence rates (which need to be at least 16.1% for cost-effectiveness), are critical factors influencing the overall economics of CPAP therapy, providing insights for healthcare policymakers.
Background: Streptococcus pneumoniae has been estimated to cause 9·18 million cases of pneumococcal pneumonia, meningitis, and invasive non-pneumonia non-meningitis disease and 318 000 deaths among children younger than 5 years in 2015. We estimated the potential impact and cost-effectiveness of pneumococcal conjugate vaccine (PCV) introduction.
Methods: We updated our existing pseudodynamic model to estimate the impact of 13-valent PCV (PCV13) in 112 low-income and middle-income countries by adapting our previously published pseudodynamic model with new country-specific evidence on vaccine coverage, burden, and post-introduction vaccine impact from WHO-UNICEF estimates of national immunisation coverage and a global burden study.